Send someone a link to this article. They'll recieve an email with a your name, a link to the article and an optional message.

NYSSA • The New York State Society of Anesthesiologists, Inc.

Back to "In This Issue"

Volume 78 Number 03

SUZETRIGINE: A New Kid on the Block?

This new drug can integrate into anesthesia-based strategies and recovery pathways for treating acute postsurgical pain—and be included in opioid stewardship efforts. It is the first FDA-approved non-opioid medication that represents a groundbreaking advancement in acute pain management.

You'll have to be logged in to keep reading.

NYSSA Supporter
MLMIC Insurance Company
Endorsed Vendors
Charles J. Sellers & Co MLMIC Insurance Company Garfunkel Wild, P.C.

Website design, development and hosting by MAjor Designs